-
Worth Watching Stocks: Mirati Therapeutics (NASDAQ:MRTX), Revance Therapeutics (NASDAQ:RVNC), Pfizer Inc. (NYSE:PFE), Silicon Laboratories Inc. (NASDAQ:SLAB), Ericsson (NASDAQ:ERIC)
On Thursday shares of Mirati Therapeutics, Inc. (NASDAQ:MRTX) closed at $29.90. Mirati Therapeutics, Inc. (NASDAQ:MRTX) reported financial results for the first quarter ended March 31, 2015 and provided an update on its drug development programs. Cash, cash equivalents, and short-term investments were $68.0 million at March 31, 2015, compared to $29.3 million at December 31,…
-
Fast Moving Stocks: Southwest Airlines Co. (NYSE:LUV), Kinross Gold Corporation (NYSE:KGC), Superior Drilling Products (NYSEMKT:SDPI), Revance Therapeutics (NASDAQ:RVNC), Embraer (NYSE:ERJ)
On Wednesday shares of Southwest Airlines Co. (NYSE:LUV) closed at $40.95. Company’s sales growth for last 5 years was 12.40% and EPS growth for next 5 years is recorded as 29.60%. Deutsche Bank reaffirmed their buy rating on shares of Southwest Airlines (NYSE:LUV) in a research note issued to investors on Monday. The firm currently…
-
Don’t Miss: JD.com (NASDAQ:JD), Freshpet (NASDAQ:FRPT), Analog Devices (NASDAQ:ADI), DBV Technologies S.A. (NASDAQ:DBVT), Revance Therapeutics (NASDAQ:RVNC)
On Wednesday shares of JD.com, Inc. (NASDAQ:JD) closed at $32.66. Company’s sales growth for last 5 years was 108.50% and EPS growth for next 5 years is recorded as 30.51%. JD.com, Inc. (NASDAQ:JD), expects a warehousing and delivery agreement with Japan’s Uniqlo Co. will open the door for more companies to use its logistics services.…
-
Big Movers: Infinity Pharmaceuticals (NASDAQ:INFI), Revance Therapeutics (NASDAQ:RVNC), Delta Air Lines (NYSE:DAL), Methes Energies International (NASDAQ:MEIL), Cisco Systems (NASDAQ:CSCO)
On Tuesday shares of Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) closed at $13.98. Company’s sales growth for last 5 years was 26.60% and EPS growth for next 5 years is recorded as 3.00%. Analysts at TheStreet downgraded shares of Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) from a “hold” rating to a “sell” rating in a research note. Revance Therapeutics,…
-
Mix Sector Stocks: IAC/InterActiveCorp (NASDAQ:IACI), Ericsson (NASDAQ:ERIC), NewMarket Corporation (NYSE:NEU), Clayton Williams Energy (NYSE:CWEI), Revance Therapeutics (NASDAQ:RVNC)
Morgan Stanley assumed coverage on shares of IAC/InterActiveCorp (NASDAQ:IACI) in a research note issued to investors on Wednesday, TheFlyOnTheWall.comreports. The firm issued an underweight rating and a $48.00 price target on the stock. On Wednesday shares of IAC/InterActiveCorp (NASDAQ:IACI) closed at $68.46. Company’s sales growth for last 5 years was 18.20% and EPS growth for…
-
Stocks Buzz: Revance Therapeutics (NASDAQ:RVNC), VisionChina Media Inc. (NASDAQ:VISN), Ciber (NYSE:CBR), The Bank of Nova Scotia (NYSE:BNS), American Equity Investment Life (NYSE:AEL)
Revance Therapeutics, Inc. (NASDAQ:RVNC), announced that its management is scheduled to participate in the Cowen and Company 35th Annual Health Care Conference in Boston. Revance management is scheduled to present on Tuesday, March 3, 2015 at 8:40 am ET. On Tuesday shares of Revance Therapeutics, Inc. (NASDAQ:RVNC) closed at $16.61. VisionChina Media Inc. (NASDAQ:VISN) in…
-
Stocks Swings: Cabot Oil & Gas Corporation (NYSE:COG), ChemoCentryx (NASDAQ:CCXI), Oncothyreon Inc (NASDAQ:ONTY), Nova Lifestyle (NASDAQ:NVFY), Revance Therapeutics (NASDAQ:RVNC)
Cabot Oil & Gas Corporation (NYSE:COG) will host its fiscal year-end and fourth quarter 2014 earnings conference call on Friday, February 20, 2015 at 9:30 a.m. Eastern Time. The Company plans to issue its financial and operating results prior to the market opening on the same day.On Thursday shares of Cabot Oil & Gas Corporation…
-
Biotech Insider Selling: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Revance Therapeutics (NASDAQ:RVNC), Aratana Therapeutics (NASDAQ:PETX), Agenus Inc. (NASDAQ:AGEN), Albany Molecular Research (NASDAQ:AMRI)
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) CEO Jean Jacques Bienaime sold 2,000 shares of BioMarin Pharmaceutical stock in a transaction that occurred on Friday, January 9th. The shares were sold at an average price of $94.14, for a total transaction of $188,280.00. Following the completion of the sale, the chief executive officer now directly owns 225,157 shares…